Advanced search
Publication Cover
Leukemia & Lymphoma Volume 56, 2015 - Issue 12
Submit an article Journal homepage
405
Views
12
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Chronic myeloid leukemia with e14a3 BCR-ABL transcript: analysis of characteristics and prognostic significance

Gui XiaominThe First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis, Suzhou, PR China
,
Zhang YongThe First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis, Suzhou, PR China;The Jinan Military General Hospital, Jinan, PR China
,
Pan JinlanThe First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis, Suzhou, PR ChinaCorrespondence[email protected]
,
Qiu HuiyingThe First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis, Suzhou, PR China
,
Cen JiannongThe First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis, Suzhou, PR China
,
Xue YongquanThe First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis, Suzhou, PR China
,
Chen SuningThe First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis, Suzhou, PR China
,
Shen HongjieThe First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis, Suzhou, PR China
,
Yao LiThe First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis, Suzhou, PR China
,
Zhang JunThe First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis, Suzhou, PR China
,
Wu YafangThe First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis, Suzhou, PR China
&
Chen YanThe First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis, Suzhou, PR China
 show all
Pages 3343-3347 | Received 07 Apr 2014, Accepted 29 Mar 2015, Published online: 19 Jun 2015

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Mengxing Xue, Qinrong Wang, Li Huo, Lijun Wen, Xiaofei Yang, Qian Wu, Jinlan Pan, Jiannong Cen, Changgeng Ruan, Depei Wu & Suning Chen. (2019) Clinical characteristics and prognostic significance of chronic myeloid leukemia with rare BCR-ABL1 transcripts. Leukemia & Lymphoma 60:12, pages 3051-3057.
Read now

Articles from other publishers (11)

Ajeet Kumar, Vatsal Mishra, Chandra Bhan Singh, Rashmi Patel, Siddharth Samrat, Madhukar Rai, Nilesh Kumar, Vijay Tilak, Vineeta Gupta & Akhtar Ali. (2023) Higher incidence of co-expression of BCR-ABL fusion transcripts in an Eastern Indian population. Egyptian Journal of Medical Human Genetics 24:1.
Crossref
Jayesh Saha, Vipin Gopinath, ChandranK Nair & Deepak Roshan. (2023) Identification of rare atypical BCR-ABL1 transcript: A case report. Indian Journal of Pathology and Microbiology 66:3, pages 624.
Crossref
Xupai Zhang, Haoping Sun, Yi Su & Hai Yi. (2022) Long-Term Molecular Remission after Treatment with Imatinib in a Chronic Myeloid Leukemia Patient with Extreme Thrombocytosis Harboring Rare e14a3 (b3a3) BCR::ABL1 Transcript: A Case Report. Current Oncology 29:11, pages 8171-8179.
Crossref
Michele Massimino, Elena Tirrò, Stefania Stella, Livia Manzella, Maria Stella Pennisi, Chiara Romano, Silvia Rita Vitale, Adriana Puma, Cristina Tomarchio, Sandra Di Gregorio, Agostino Antolino, Francesco Di Raimondo & Paolo Vigneri. (2021) Impact of the Breakpoint Region on the Leukemogenic Potential and the TKI Responsiveness of Atypical BCR-ABL1 Transcripts. Frontiers in Pharmacology 12.
Crossref
Hu Zhao, Yuan Chen, Chanjuan Shen, Lingshu Li, Qingzhao Li, Kui Tan, Huang Huang & Guoyu Hu. (2020) Breakpoint mapping of a t(9;22;12) chronic myeloid leukaemia patient with e14a3 BCR‐ABL1 transcript using Nanopore sequencing. The Journal of Gene Medicine 23:1.
Crossref
Mireille Crampe, Stephen E. Langabeer, David O'Brien, Eileen Ryan & C. Larry Bacon. (2020) Philadelphia chromosome-positive acute lymphoblastic leukemia with an e14a3 BCR-ABL1 fusion: The role of molecular monitoring. Hematology/Oncology and Stem Cell Therapy 13:3, pages 166-167.
Crossref
Michele Massimino, Stefania Stella, Elena Tirr�, Maria Consoli, Maria Pennisi, Adriana Puma, Silvia Vitale, Chiara Romano, Valentina Zammit, Fabio Stagno, Francesco Di Raimondo & Livia Manzella. (2019) Rapid decline of Philadelphia‑positive metaphases after nilotinib treatment in a cml patient expressing a rare e14a3 bcr‑abl1 fusion transcript: A case report. Oncology Letters.
Crossref
Ya-Zhen Qin, Qian Jiang, Hao Jiang, Yue-Yun Lai, Hong-Xia Shi, Wen-Min Chen, Lu Yu & Xiao-Jun Huang. (2018) Prevalence and outcomes of uncommon BCR-ABL1 fusion transcripts in patients with chronic myeloid leukaemia: data from a single centre . British Journal of Haematology 182:5, pages 693-700.
Crossref
A. K. Arun, A. Senthamizhselvi, S. Mani, K. Vinodhini, N. B. Janet, K. M. Lakshmi, A. Abraham, B. George, A. Srivastava, V. M. Srivastava, V. Mathews & P. Balasubramanian. (2017) Frequency of rare BCR-ABL1 fusion transcripts in chronic myeloid leukemia patients . International Journal of Laboratory Hematology 39:3, pages 235-242.
Crossref
Preetesh JainHagop KantarjianKeyur P. Patel, Graciela Nogueras Gonzalez, Rajyalakshmi Luthra, Rashmi Kanagal Shamanna, Koji SasakiElias JabbourCarlos Guillermo RomoTapan M. KadiaNaveen PemmarajuNaval DaverGautam BorthakurZeev EstrovFarhad RavandiSusan O’Brien & Jorge Cortes. (2016) Impact of BCR-ABL transcript type on outcome in patients with chronic-phase CML treated with tyrosine kinase inhibitors. Blood 127:10, pages 1269-1275.
Crossref
. (2016) Dasatinib. Reactions Weekly 1585:1, pages 95-95.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.